The research team, led by Madison Balagtas and supervised by Ashley E. Levack of the Department of Orthopaedic Surgery and Rehabilitation at Loyola University Medical Center, set out to fill a conspicuous gap in the literature. Previous comparisons of antiseptic solutions had relied largely on static well-plate models and focused on arthroplasty surfaces such as porous titanium, polymethylmethacacrylate cement, cobalt-chromium, and oxidized zirconium. Stainless steel, despite being the most widely used metal in plates, screws, and nails for fracture fixation, had never been directly tested for its susceptibility to antiseptic irrigation. Moreover, static models fail to capture the hydrodynamic conditions that shape biofilm architecture in real wounds, where fluids constantly move and shear forces sculpt the microbial community into structures quite different from those grown in a motionless dish.

To address both shortcomings, the investigators turned to the CDC biofilm reactor, a validated laboratory system that grows reproducible biofilms under continuous flow. Sterile disk-shaped coupons made of 316L stainless steel, ten millimeters in diameter, were mounted in polypropylene holders inside the reactor vessel containing five hundred milliliters of tryptic soy broth. The system was inoculated with methicillin-sensitive S. aureus strain ATCC 49230 at approximately one hundred thousand colony-forming units per milliliter and operated in batch mode for twenty-four hours at thirty-seven degrees Celsius with gentle stirring. It then switched to continuous-flow mode for another forty-eight hours, with dilute medium pumped through the vessel at 6.94 milliliters per minute, delivering roughly twenty liters over the flow phase. By the end of the seventy-two-hour cultivation period, the coupons carried mature, flow-conditioned biofilms that more closely approximate the hydrodynamic environment of a surgical field than any static culture could.

The treatment phase was deliberately simple and clinically grounded. Each biofilm-coated coupon was rinsed gently in phosphate-buffered saline to remove non-adherent planktonic cells, then submerged for exactly three minutes in one of six irrigation solutions: normal saline, ten percent povidone-iodine, 0.35 percent povidone-iodine diluted in saline, a one-to-one mixture of ten percent povidone-iodine with three percent hydrogen peroxide, a commercial hypochlorous acid wound solution, or a 0.05 percent chlorhexidine gluconate lavage. The three-minute dwell time mirrors established orthopedic irrigation protocols and matches the conditions used in prior comparative studies, allowing direct comparison across investigations. Untreated controls and saline groups were included in every experimental run to separate the mechanical effect of rinsing from genuine chemical antibiofilm activity.

Quantifying what survived the treatment required careful biofilm disruption. Coupons were transferred to tubes of fresh medium and subjected to probe sonication at approximately seventeen to eighteen watts, using a manual pulsing rhythm of five seconds on and five seconds off for a cumulative five minutes of active sonication, with samples kept on ice throughout to prevent heat damage. The resulting suspensions were serially diluted, spread-plated onto agar in triplicate, incubated overnight, and counted. The entire protocol, from bacterial culture through colony enumeration, was repeated on four separate dates, with three coupons per treatment per run and three agar plates per coupon, yielding 252 plates across all runs and groups. Statistical analysis employed a mixed-effects negative binomial regression model, an approach well suited to the overdispersed count data typical of biofilm experiments, with experimental date as a fixed effect and culture plate as a random effect, and robust sandwich standard errors to guard against model misspecification.

The results were striking. Every antiseptic solution produced a statistically significant reduction in viable bacteria compared with untreated controls, but the magnitude varied enormously. Ten percent povidone-iodine achieved the greatest effect, a 3.46-log10 reduction equivalent to 99.97 percent killing, leaving only about 2,300 colony-forming units per milliliter against a control burden of nearly 6.8 million. Remarkably, the dilute 0.35 percent formulation performed almost identically, with a 3.42-log10 reduction and 99.96 percent killing. The difference between full-strength and dilute povidone-iodine was a negligible 0.04 logs, and their confidence intervals overlapped substantially. Both concentrations comfortably surpassed the three-log10 reduction threshold widely used as an operational benchmark for bactericidal antibiofilm activity in orthopedic biofilm research.

The remaining solutions trailed behind. The povidone-iodine and hydrogen peroxide mixture achieved a 3.24-log10 reduction, still above the threshold but slightly inferior to povidone-iodine alone, with no evidence of the synergistic enhancement some prior work had suggested. Hypochlorous acid delivered a 2.95-log10 reduction and chlorhexidine gluconate a 2.46-log10 reduction, both exceeding 99 percent killing yet falling short of the three-log benchmark. Chlorhexidine-treated coupons retained roughly tenfold more viable bacteria than the povidone-iodine groups. Normal saline, the default irrigant in many operating rooms, managed only a 0.15-log10 reduction, or about 30 percent, leaving bacterial burdens within the same order of magnitude as untreated controls. In practical terms, for every ten thousand bacteria on an untreated coupon, only three would remain after ten percent povidone-iodine treatment, whereas saline would leave roughly seven thousand behind.

The equivalence of dilute and full-strength povidone-iodine may prove to be the study’s most consequential finding. Surgeons frequently dilute ten percent povidone-iodine out of concern for cytotoxicity to osteoblasts, fibroblasts, and other host cells, since in vitro evidence shows that concentrations of 0.1 percent and above can impair the survival and migration of these cell types. Yet clinical series have not consistently linked intraoperative povidone-iodine irrigation to adverse wound healing. The new data suggest that such dilution may cost little in antibiofilm potency, a reassuring combination of preserved efficacy and reduced tissue toxicity. Mechanistically, povidone-iodine releases free molecular iodine that oxidizes microbial membrane lipids, proteins, and nucleic acids, and dilute formulations may release a higher proportion of free iodine relative to total iodine content, potentially explaining the preserved activity at 0.35 percent. Earlier work by Oduwole and colleagues also showed that even sub-inhibitory povidone-iodine concentrations suppress staphylococcal biofilm formation by downregulating the icaADBC operon, complementing the present findings on established biofilms.

Intriguingly, the results diverge from a 2025 study by Chao and colleagues, who found that 0.35 percent povidone-iodine and 0.05 percent chlorhexidine both failed to achieve a three-log reduction against mature S. aureus biofilms on cobalt-chromium and oxidized zirconium surfaces in a static model. The Loyola team hypothesizes that biofilms grown under continuous flow in the CDC reactor may differ structurally from static well-plate biofilms in ways that improve antiseptic penetration, and that surface material and bacterial strain differences may also contribute. These model-dependent discrepancies underscore why testing across multiple biofilm systems and implant surfaces matters before drawing firm clinical conclusions. Similarly, the absence of synergy in the povidone-iodine and hydrogen peroxide mixture contrasts with a study by Wan and colleagues that applied the two agents sequentially with double the total contact time, highlighting how concentration, sequence, and exposure duration can reshape apparent drug interactions.

The authors are careful to frame their findings within the limits of the model. The experiments used a single organism, methicillin-sensitive S. aureus, whereas chronic implant infections often involve methicillin-resistant strains, coagulase-negative staphylococci, gram-negative bacteria, and polymicrobial communities whose antiseptic susceptibility may differ. Only stainless steel was tested, the static three-minute soak ignores the mechanical forces of pulse lavage that contribute to bacterial debridement in the operating room, colony counting was performed without formal blinding, and cytotoxicity to bone and soft tissue was not assessed. Notably, the Fracture-Related Infection Consensus Group currently recommends low-pressure saline irrigation and does not advise antiseptic additives, citing cytotoxicity concerns. This study does not overturn that guidance, but it adds meaningful in vitro evidence to an ongoing debate, establishing a comparative efficacy baseline on a fracture-fixation-relevant surface and justifying further translational work with multiple species, realistic irrigation workflows, and paired cytotoxicity profiling before antiseptic irrigation practice changes at the bedside.

Subject of Research: Antiseptic irrigation efficacy against Staphylococcus aureus biofilms on stainless steel orthopedic implants

Article Title: In vitro analysis of antiseptic solution effects on Staphylococcus aureus biofilms on orthopedic implant materials

Article References: Balagtas, M., Chrulski, K., Feffer, M., Baldridge, M., & Levack, A. E. (2026). In vitro analysis of antiseptic solution effects on Staphylococcus aureus biofilms on orthopedic implant materials. Journal of Bone and Joint Infection, 11(4), 493-501. https://doi.org/10.5194/jbji-11-493-2026

Image Credits: AI Generated

DOI: 10.5194/jbji-11-493-2026

Keywords: biofilm, Staphylococcus aureus, povidone-iodine, orthopedic implants, stainless steel, antiseptic irrigation, CDC biofilm reactor, chlorhexidine, hypochlorous acid, fracture-related infection, surgical debridement, antibiotic tolerance

The problem the authors set out to address is rooted in the peculiar biology of newborn skin. In preterm infants, the stratum corneum, the outermost barrier layer of the epidermis, is thin and poorly keratinized, which means the skin offers far less resistance to microorganisms and loses water far more rapidly than adult skin. This immaturity drives increased transepidermal water loss and leaves the skin fragile and prone to injury. At the same time, neonates who need intravenous nutrition, medications, or hemodynamic support often carry catheters for weeks, and every dressing change or manipulation of the device creates another opportunity for contamination, skin stripping, or accidental dislodgement. The combination of immature skin, prolonged catheter dwell times, and repeated handling makes the exit site a critical bottleneck in neonatal intensive care, where failures translate directly into catheter-related bloodstream infections, medical adhesive-related skin injury, dressing failure, and loss of vascular access that may be difficult or impossible to replace.

The recommendation covers the full range of devices used in neonatal units, including peripheral venous access devices, central venous access devices such as peripherally inserted central catheters, epicutaneo-caval catheters, femorally and centrally inserted central catheters, umbilical venous and arterial catheters, and intra-arterial lines. Each device type presents a slightly different exit site anatomy and risk profile, but the authors argue that the underlying principles of assessment, antisepsis, securement, and monitoring should be standardized across all of them. Standardization, they contend, is what allows a unit to detect deterioration early, compare outcomes over time, and reduce the unexplained variation in practice that has long characterized neonatal care from one center to another.

Central to the recommendation is the systematic assessment of both the exit site and the surrounding skin. Clinicians are advised to inspect the site at defined intervals, documenting the appearance of the skin, the presence of redness, swelling, or exudate, the integrity of the dressing, and the external catheter length, since a change in the length of catheter protruding from the skin is a classic early sign of migration. The authors emphasize the use of validated neonatal skin assessment tools, drawing on instruments such as the Neonatal Skin Condition Score, to make observations reproducible rather than subjective. Because adhesive-related injury is a well-recognized hazard in very preterm infants, the guidance also stresses careful technique when applying and removing dressings and adhesives, including the use of adhesive removers and gentle peel techniques to avoid stripping the fragile epidermis.

On the question of asepsis, the recommendation endorses the Aseptic Non Touch Technique framework, known as ANTT, distinguishing between Standard-ANTT for procedures involving small key sites and key parts, such as routine exit site care and dressing changes, and Surgical-ANTT for procedures that require a larger sterile field, such as catheter insertion. The ANTT approach, which originated in the United Kingdom and has been adopted widely across Europe, rests on the principle of identifying the key parts of the equipment and the insertion site that must remain free of microorganisms and protecting them from contact with non-sterile surfaces throughout the procedure. The authors point to quality improvement studies showing that standardizing and improving compliance with aseptic non-touch technique can reduce healthcare-associated infections in neonatal units, and they argue that a shared, teachable framework is more reliable than idiosyncratic local habits.

Skin antisepsis before and around catheter care is addressed with specific attention to gestational age, a nuance that distinguishes neonatal practice from adult guidelines. Chlorhexidine-based solutions are recommended as the agents of choice, consistent with their broad-spectrum activity and residual effect, but the concentration and formulation must be adapted to the maturity of the infant’s skin. Recent randomized feasibility work in preterm neonates, including the Arctic trial comparing 2% chlorhexidine gluconate in aqueous solution with 2% chlorhexidine gluconate in 70% isopropyl alcohol, illustrates the ongoing effort to balance antimicrobial efficacy against the risk of chemical burns and skin irritation in extremely immature skin. Alcohol-based preparations act faster and leave less residue, but they carry a higher risk of skin injury in preterm infants and must be allowed to dry fully; aqueous formulations may be preferred for the most fragile patients. The recommendation instructs clinicians to remove antiseptic residue after the procedure to limit cumulative exposure of the developing skin.

Perhaps the most technically distinctive elements of the guidance concern securement. Traditional suture fixation is problematic in neonates because sutures create additional skin breaks and infection risks, so the authors advocate sutureless securement strategies. One approach uses subcutaneously anchored sutureless devices that stabilize the catheter hub without penetrating the skin. The other, increasingly popular in European centers, is cyanoacrylate tissue adhesive, specifically octyl-butyl-cyanoacrylate glue, applied at the exit site to fix the catheter in place and simultaneously form a microbial barrier. Clinical studies in neonates, including randomized trials of cyanoacrylate securement for umbilical venous catheters and observational series in peripherally inserted central catheters and epicutaneo-caval catheters, have reported reductions in accidental dislodgement and promising trends in complication rates. The glue works by polymerizing on contact with tissue moisture, creating a flexible film that anchors the catheter and can be peeled away or sloughs off naturally as the skin exfoliates.

Dressing selection receives equally detailed treatment. The recommendation favors semipermeable transparent films with a high moisture vapor transmission rate, a property usually abbreviated as MVTR. This parameter, typically measured in grams of water vapor passing through a square meter of material per day, determines how well a dressing allows the skin underneath to breathe while still blocking external contaminants and maintaining a sterile field. In neonates, whose skin loses water at high rates and whose catheters may remain in place for weeks, a dressing with inadequate vapor permeability can trap moisture, causing maceration that weakens the skin barrier and promotes microbial growth, whereas an excessively permeable dressing may lose adhesion prematurely. The authors also describe dressing configurations tailored to specific devices, including setups for umbilical catheters, and provide guidance on when and how dressings should be changed, favoring change on indication, such as soiling, loosening, or visible deterioration, rather than on a fixed routine schedule that multiplies manipulation of fragile skin.

The document closes the loop with recommendations on complication monitoring and catheter removal, underscoring that exit site care does not end until the device is out and the site has healed. Clinicians are urged to maintain vigilance for local signs of infection, phlebitis, infiltration, and skin breakdown, and to remove catheters as soon as they are no longer clinically necessary, since dwell time is one of the strongest modifiable risk factors for catheter-related bloodstream infection. The authors acknowledge that the evidence base in neonates remains thinner than in adult vascular access, and that many elements of the recommendation rest on expert consensus informed by studies in related populations, a limitation they address by making the reasoning behind each element explicit.

The significance of the work lies less in any single novel technique than in its ambition to make excellent exit site care universal rather than accidental. By codifying assessment schedules, antisepsis protocols, securement technologies, and dressing standards into a single recommendation, the European group aims to give every neonatal unit, regardless of size or resources, a coherent playbook for protecting the skin-catheter interface. If widely implemented, the authors argue, standardized exit site management could reduce catheter-related infections, medical adhesive-related skin injuries, dressing failures, and device dislodgements, sparing fragile newborns painful reinsertions, prolonged antibiotic courses, and the serious systemic complications that begin, all too often, at a few square centimeters of immature skin.

Subject of Research: Evidence-based management of catheter exit sites in neonatal vascular access

Article Title: Exit site management: neonatal european vascular access team – ESPR recommendation 7

Article References: Piersigilli, F., Romitti, M. G., Van Eenoo, S., van der Lee, R., Hugill, K., van Rens, M., Iacona, G., Barone, G., Rodriguez-Perez, C., on behalf of the Pediatric and Neonatal Vascular Access SIG of the ESPR and NEVAT, Van Eenoo, S., van der Lee, R., van Rens, M., Debuf, M.-J., Milan, A., Yousef, N., Schwaberger, B., Pittiruti, M., Werther, T., … Tuna, M. L. (2026). Exit site management: neonatal european vascular access team – ESPR recommendation 7. Pediatric Research. https://doi.org/10.1038/s41390-026-05471-w

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05471-w

Keywords: neonatology, vascular access, catheter exit site, ANTT, chlorhexidine, cyanoacrylate glue, sutureless securement, transparent dressings, MVTR, catheter-related infection, medical adhesive-related skin injury, ESPR recommendations

The document is the eighth recommendation in a series produced by the Pediatric and Neonatal Vascular Access Special Interest Group of the European Society for Paediatric Research, working together with NEVAT, a European network of vascular access specialists. The series is designed to cover the entire process of neonatal vascular access, and this installment focuses squarely on infection prevention. Its central message is that safe catheter care is not a single intervention but a chain of practices that must remain unbroken across insertion, maintenance and discontinuation, and that standardized protocols for assessment, insertion and evaluation are essential if units are to protect their most vulnerable patients.

The stakes could hardly be higher. Central-line-associated bloodstream infections, often abbreviated as CLABSI, remain a significant burden in neonatal intensive care, and Dutch surveillance data cited by the authors show that these infections continue to occur even in well-resourced units. For a premature infant, a bloodstream infection is not merely a temporary setback. Research summarized in the recommendation links neonatal sepsis to impaired neurocognitive outcomes, and studies of extremely preterm children show that late-onset meningitis and Candida infections are associated with worse neurodevelopmental trajectories. In other words, an infection that enters through a catheter can alter the course of a child’s entire life, which is why the authors argue that infection prevention strategies are key to safe neonatal vascular access.

Technically, the recommendation weaves together international guidance with adaptations specific to the neonatal intensive care unit. The authors draw on the ninth edition of the Infusion Therapy Standards of Practice, widely regarded as the reference framework for infusion care, as well as infection control strategies for acute-care hospitals updated in 2022 and a dedicated white paper series offering practical approaches to preventing central-line-associated bloodstream infections in neonatal units. The goal, the team explains, is to reduce the microbial burden around vascular devices by combining evidence-based measures with the practical realities of caring for infants who may weigh less than a kilogram and whose skin, immune system and veins are all uniquely vulnerable.

One of the technical pillars of the recommendation is aseptic technique, and in particular the Aseptic Non Touch Technique, known as ANTT. This practice framework, illustrated in one of the article’s figures, is built on the principle that the key parts of a vascular system, such as catheter hubs, connectors and injection ports, must never come into contact with non-sterile surfaces or hands. Studies from London hospitals and quality improvement projects in other settings have shown that improving compliance with ANTT during intravenous line maintenance can reduce healthcare-associated infections. By embedding this framework in neonatal practice, the European team aims to make the standard of asepsis uniform rather than dependent on the habits of individual clinicians or units.

Skin disinfection is another area where the recommendation engages with rapidly evolving evidence. The choice of antiseptic for central catheter insertion in neonates has long been contested, because chlorhexidine, the workhorse antiseptic in adult care, carries concerns about skin injury in premature infants. The authors reference a Cochrane review of antiseptic solutions for neonatal central catheter insertion and recent clinical trials comparing 2 percent chlorhexidine gluconate in 70 percent isopropyl alcohol with aqueous preparations, including the Arctic randomized feasibility trial. These studies reflect a genuine effort to determine which agent best balances antimicrobial efficacy against the delicate skin of a preterm infant, and the recommendation situates itself within this ongoing debate rather than pretending it is settled.

The recommendation also emphasizes that infection prevention begins before any catheter is inserted, with careful assessment of the infant’s veins and a deliberate choice of the most appropriate device. The authors cite the Assessment Better before Access project, a retrospective cohort study of neonatal intravascular device outcomes, and a pre-procedural systematic evaluation of superficial veins designed to optimize venous catheterization. The logic is straightforward: every failed peripheral attempt creates additional entry points for microorganisms and additional skin trauma, so choosing the right device the first time is itself an infection prevention measure. Consensus algorithms for selecting venous access in newborns, including work from Italian neonatal groups on umbilical venous catheters and epicutaneo-caval catheters, inform this assessment-first philosophy.

Once a line is in place, securement and dressing choices become critical to keeping microbes out. The recommendation discusses cyanoacrylate glue, a medical adhesive that seals the catheter entry site and has been tested in randomized trials for umbilical venous catheters and in observational studies for peripheral and central catheters in neonates, with evidence suggesting it can reduce complications as part of a broader bundle. It also considers subcutaneously anchored securement devices and modern dressing technologies, including dialkylcarbamoylchloride-coated dressings for catheter exit sites and the material properties of transparent semipermeable films. Each of these technologies aims to prevent the micro-movements of the catheter within the tract that allow skin flora to migrate inward, while also protecting the fragile skin from medical adhesive-related injuries, a recognized problem in neonatal units.

Perhaps the most distinctive feature of the recommendation is its attention to the social dimension of neonatal care. The authors highlight evidence that parent-infant skin-to-skin contact can be maintained even during peripheral catheter insertion, and they situate infection prevention within the broader movement toward family integrated care, in which parents are trained partners rather than visitors. Recent clinical trial data on close collaboration with parents in neonatal units and studies of family management skills suggest that involving families does not compromise safety and may enhance it. Hand hygiene, the subject of a Cochrane review on preventing infections in neonates, remains the simplest and most powerful tool available to staff and parents alike, and the recommendation frames it as a shared responsibility across the entire care environment.

Finally, the recommendation addresses the end of the catheter’s life. Timely discontinuation, careful removal technique and ongoing surveillance for bloodstream infection all form part of the lifecycle approach. The authors point to Dutch work on sustainable CLABSI surveillance and consensus toward new criteria, reflecting a European effort to measure these infections consistently so that units can compare performance and improve. Taken together, the document represents a rare attempt to consolidate scattered evidence into a single, practical standard for neonatal vascular access across the continent. For the clinicians who care for the smallest patients, and for the families who trust them, the message is clear: every catheter is a lifeline and a liability at once, and only disciplined, standardized, evidence-based practice from insertion to removal can keep the lifeline from becoming the pathway for harm.

Subject of Research: Infection prevention strategies for neonatal vascular access catheters

Article Title: Infection prevention: neonatal European vascular access team – ESPR recommendation 8

Article References: Infection prevention: neonatal European vascular access team – ESPR recommendation 8. (n.d.). https://doi.org/10.1038/s41390-026-05464-9

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05464-9

Keywords: neonatal intensive care, vascular access, CLABSI, infection prevention, catheter insertion, aseptic non touch technique, chlorhexidine, cyanoacrylate glue, preterm infants, hand hygiene, family integrated care, ESPR

The research, conducted by Maoting Chen and Qianling Wei of the Department of Critical Care Medicine at West China Hospital of Sichuan University and the West China School of Nursing, examined the records of 124 pediatric patients who were hospitalized in intensive care wards after complex cardiac surgery between June 30, 2008 and December 31, 2022. The researchers asked a deceptively straightforward question: did children who received daily oral care during their perioperative period experience fewer adverse clinical events than those who did not? The two outcomes of primary interest were sepsis, the life-threatening systemic response to infection, and deteriorated heart function, both of which are among the most feared complications following pediatric cardiac procedures.

The answer, according to the study’s statistical analysis, was yes. Among the 124 children studied, sepsis occurred in 16 patients, an incidence of 12.9 percent, while deteriorated heart function was observed in 23 patients, or 18.5 percent. When the researchers applied multivariate logistic regression, a statistical technique that adjusts for the influence of multiple variables simultaneously, they found that children who had not received oral health care faced markedly higher risks. In the study’s fully adjusted model, the risk of sepsis was significantly elevated in patients without oral care, with an adjusted odds ratio of 2.32 and a 95 percent confidence interval of 1.36 to 4.32, corresponding to a P value of 0.026. The risk of deteriorated heart function was also higher, with an adjusted odds ratio of 1.83, a confidence interval of 1.09 to 3.14, and a P value of 0.039.

Those numbers translate into a compelling clinical message. An odds ratio of 2.32 means that, after accounting for other factors, children who did not receive daily oral care had more than twice the odds of developing sepsis compared with those who did. For deteriorating cardiac function, the odds were nearly doubled. In both cases, the confidence intervals exclude the value of 1.0, which is the statistical threshold indicating no effect, and the P values fall below the conventional 0.05 significance level. The researchers also performed sensitivity analyses, which are repeated analyses designed to test whether a finding holds up under different assumptions or model specifications, and these continued to indicate that daily oral care contributed to a reduced risk of both sepsis and declining cardiac function in pediatric patients after cardiac surgery.

Perhaps the most intriguing detail to emerge from the study concerns the choice of rinsing agent. The negative association between oral health and adverse outcomes, meaning the protective relationship, was stronger among patients who used a 2 percent oral chlorhexidine rinse than among those who used 0.9 percent physiological saline. Chlorhexidine is an antiseptic agent widely used in hospitals to suppress the microbial load in the mouth, and the finding suggests that the composition of the oral rinse may matter, not merely the act of rinsing itself. Saline, while helpful for mechanical clearance of debris and microorganisms, lacks the sustained antimicrobial activity that chlorhexidine provides. This nuance could inform future protocols for oral hygiene in pediatric intensive care settings.

The biological rationale behind these findings is grounded in well-established oral-systemic pathways. The mouth harbors a dense and diverse microbial community, and in critically ill patients this community can shift toward pathogenic species. Intubation, sedation, and mechanical ventilation, all routine in complex cardiac surgery, bypass the natural defenses of the upper airway and can allow oral bacteria to colonize the lower respiratory tract. From there, microorganisms or their products can enter the bloodstream, triggering the systemic inflammatory cascade that defines sepsis. Inflammation itself can further stress a heart that has just been subjected to the trauma of cardiopulmonary bypass and surgical repair, creating a vicious cycle in which infection and cardiac dysfunction reinforce one another. By reducing the microbial burden in the mouth, daily oral care may interrupt this cycle at its earliest and most accessible stage.

Children undergoing complex cardiac surgery represent a particularly high-risk population for these mechanisms. Their immune systems are still developing, their physiological reserves are limited, and the surgical procedures they undergo are among the most invasive in pediatric medicine. Postoperative sepsis in this group is associated with prolonged intensive care stays, additional organ support, and increased mortality, while deteriorating cardiac function can necessitate escalated mechanical support or reintervention. Any intervention that is inexpensive, noninvasive, and deliverable at the bedside therefore carries substantial potential value for this population, and oral care fits that description precisely.

The study’s design warrants careful interpretation. As a retrospective analysis, it examined existing records rather than prospectively assigning patients to receive or forgo oral care, which means that unmeasured differences between the two groups could have influenced the results. The authors note that the research was approved by the Ethics Committee of West China Hospital of Sichuan University in accordance with the Helsinki Declaration and national regulations, and that informed consent from patients’ parents or legal guardians was waived because most individuals had been discharged and could not be contacted. The use of multivariate regression and sensitivity analysis strengthens the findings, but the association reported here is exactly that, an association, and randomized controlled trials would be needed to establish a definitive causal relationship between daily oral care and reduced adverse events.

Even with those caveats, the study contributes to a broader shift in how critical care medicine views the mouth. Oral health has been increasingly linked to a range of clinical complications, and maintaining good oral care has become recognized as one of the important interventions to reduce the risk of adverse clinical events. Yet, as the authors point out, the association of oral health care with sepsis and cardiac function has remained controversial, with prior evidence inconsistent. By focusing specifically on children after complex cardiac surgery, a population in which both outcomes are frequent and consequential, and by demonstrating statistically significant associations for both, the new research provides further evidence for the importance of oral health in reducing adverse clinical events, particularly in critically ill pediatric patients.

The practical implications are likely to resonate with intensive care teams worldwide. Daily oral care is among the least expensive interventions available in an ICU, requiring little more than trained nursing time, toothbrushes or swabs, and a rinsing solution. If the associations observed here are confirmed in prospective studies, standardizing perioperative oral hygiene protocols for children undergoing cardiac surgery could become a low-cost, high-value component of postoperative care, with the choice of chlorhexidine over saline potentially amplifying the benefit. For the families of the hundreds of thousands of children who undergo cardiac surgery each year, the message from this research is quietly remarkable: one of the keys to protecting a repaired heart may lie not in the operating theater but in the daily, unglamorous care of a child’s mouth.

Subject of Research: The association between perioperative oral care and postoperative sepsis and cardiac function in children after complex cardiac surgery

Article Title: The association between perioperative oral care and adverse clinical events after complex cardiac surgery in children

Article References: Chen, M., & Wei, Q. (2026). The association between perioperative oral care and adverse clinical events after complex cardiac surgery in children. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07406-0

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07406-0

Keywords: oral care, sepsis, cardiac function, pediatric cardiac surgery, intensive care unit, chlorhexidine, oral hygiene, children, critical care, infection prevention, retrospective study, BMC Pediatrics